SNFCA Form 4: H. Craig Moody adds 627 Class A shares; options detailed
Rhea-AI Filing Summary
Security National Financial Corp (SNFCA) director H. Craig Moody reported share and option activity on a Form 4. The filing shows the acquisition of 627 Class A shares via a restricted stock unit vesting event at a price of $13.08, increasing his direct non-derivative holdings to 43,702 shares. The report also details multiple outstanding director stock options and previously granted restricted stock units, which together result in beneficial ownership of 61,276 Class A shares when including exercisable options and RSUs.
The filing documents option grants from 2016–2024 with exercise prices adjusted for stock dividends and vesting/exercise windows ranging through 2033. The newly vested units will be fully vested on 12/31/2025 per the disclosed schedule.
Positive
- Director acquired 627 RSUs that increase direct alignment with shareholders at $13.08
- Comprehensive disclosure of directors' options and RSUs with adjusted exercise prices shows governance transparency
- Vesting schedule provided with full vesting on 12/31/2025, making timing of ownership changes clear
Negative
- Meaningful potential dilution exists from outstanding director options and RSUs totaling 61,276 shares if exercised or vested
- Concentration of option expirations across 2026–2033 could lead to clustered share supply increases in those windows
Insights
TL;DR: Director received 627 RSUs vesting at $13.08, increasing total beneficial holdings to 61,276 shares.
The transaction listed is a restricted stock unit vesting/acquisition of 627 Class A shares at $13.08, reported under a Form 4 for a company director. The filing also itemizes serial director stock options granted from 2016 through 2023, with adjusted exercise prices reflecting repeated stock dividends.
Key dependencies include the remaining vesting windows and option expiration dates through 2033, which determine when these derivative interests can convert to shares and potentially dilute existing holders. Watch vesting completion on 12/31/2025 and option expiration clustering in the 2026–2033 range for near-term share supply changes.
TL;DR: Report confirms director-level equity compensation activity and beneficial ownership disclosure.
The Form 4 confirms the reporting person is a director and provides transparent disclosure of direct holdings (43,702 shares) plus derivative instruments and RSUs totaling 61,276 shares beneficially owned when combined. Multiple adjustments for stock dividends are documented, showing plan anti-dilution mechanics applied over several years.
This disclosure fulfills Section 16 reporting obligations and gives investors clarity on director exposure. Monitor additional periodic filings for further vesting events or option exercises that change director ownership concentration.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 627 | $13.08 | $8K |
| Exercise | Class A Common Stock | 627 | $13.08 | $8K |
| Grant/Award | Restricted Stock Unit | 1,254 | $13.08 | $16K |
| Grant/Award | Director Stock Option (right to buy) | 8,820 | $7.21 | $64K |
| Grant/Award | Director Stock Option (right to buy) | 8,104 | $5.56 | $45K |
| Grant/Award | Director Stock Option (right to buy) | 7,293 | $7.02 | $51K |
| Grant/Award | Director Stock Option (right to buy) | 7,850 | $2.84 | $22K |
| Grant/Award | Director Stock Option (right to buy) | 8,242 | $3.91 | $32K |
| Grant/Award | Director Stock Option (right to buy) | 8,657 | $3.76 | $33K |
| Grant/Award | Director Stock Option (right to buy) | 1,514 | $3.27 | $5K |
| Grant/Award | Director Stock Option (right to buy) | 1,590 | $4.52 | $7K |
| Grant/Award | Director Stock Option (right to buy) | 7,952 | $4.32 | $34K |
Footnotes (1)
- Adjusted to reflect a 5% stock dividend issued on July 18, 2025. This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025. This option was granted on December 7, 2016 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.36 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025. This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025. This option was granted on November 30, 2018 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025. This option was granted on December 6, 2019 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.46 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025. This option was granted on March 27, 2020 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $3.76 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 7, 2020, a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025. This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025. This option was granted on December 2, 2022 as an option for 7,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $6.48, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 14, 2023, July 12, 2024 and July 18, 2025. This option was granted on December 1, 2023 as an option for 8,000 shares of Class A Common Stock under the 2022 Equity Incentive Plan at an exercise price of $7.99 per share, but adjusted pursuant to the 2022 Equity Incentive Plan to reflect a 5% stock dividend paid on July 12, 2024 and July 18, 2025. These restricted stock units were granted on December 6, 2024 for 2,509 shares of Class A Common Stock under the 2022 Equity Incentive Plan at a price of $13.08 per share. The units granted vest quarterly, and will be fully vested on December 31, 2025.
